Name | 2-[(3-bromophenyl)methyl]-6,8-dichloro-1,1-dioxo-3,4-dihydro-1λ6,2,4-benzothiadiazine-3-carboxylic acid |
---|---|
Synonyms |
Rpr 104,632
RPR104632 |
Description | RPR104632 is a specific antagonist of NMDA receptor, with potent neuroprotective properties. |
---|---|
Related Catalog | |
In Vitro | RPR104632 antagonizes the binding of [3H]5,7-dichlorokynurenic acid to the rat cerebral cortex, with a Ki of 4.9 nM. RPR104632 inhibits [3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in the presence of N-methyl-D-aspartate (NMDA) (IC50 = 55 nM). RPR104632 inhibits the NMDA-evoked increase in guanosine 3',5'-cyclic monophosphate (cGMP) levels of neonatal rat cerebellar slices (IC50 = 890 nM) in a non-competitive manner and markedly reduces NMDA-induced neurotoxicity in rat hippocampal slices and in cortical primary cell cultures. MK-801 (1 μM) completely protects the CA1 and CA3 pyramidal neurones against NMDA-induced toxicity, but these effects are not blocked by glycine. RPR104632 produces a significant and consistent neuroprotective effect towards all the NMDA-induced toxicity and has no effect when it is added alone at concentrations up to 10 μM. RPR104632 has neuroprotective potencies, with EC50 of 4 μM[1]. |
References |
Density | 1.788g/cm3 |
---|---|
Boiling Point | 658.6ºC at 760mmHg |
Molecular Formula | C15H11BrCl2N2O4S |
Molecular Weight | 466.13400 |
Flash Point | 352.1ºC |
Exact Mass | 463.90000 |
PSA | 95.09000 |
LogP | 4.93970 |
Vapour Pressure | 3.04E-18mmHg at 25°C |
Index of Refraction | 1.681 |
Storage condition | 2-8℃ |